A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

NCT04540900 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Roughness
Wrinkle
Fine Lines
Skin Thickness

Interventions

BIOLOGICAL: KB301
OTHER: Placebo

Sponsor

Krystal Biotech, Inc.